Burt Adelman Net Worth & Insider Trades

Burt Adelman - Director, Verve Therapeutics, Inc

As of June 20, 2023

What is Burt Adelman's Net Worth?

The current estimated net worth of Verve Therapeutics, Inc's Director, Burt Adelman, is estimated to be about $34.72M . Burt Adelman owns about 428,326 units of Verve Therapeutics, Inc common stock. In the last 2 years at Verve Therapeutics, Inc, Burt Adelman has sold an estimated value of $0 worth.

What is Burt Adelman's Past Insider Trading?

Burt Adelman's largest purchase order was 4,700 units , worth over $147.3K on December 6, 2021. In total, Burt Adelman has made about 5 transactions over 2 years of their time at Verve Therapeutics, Inc. Burt Adelman usually trades in June, with the busiest year in 2022. The most recent transaction was a purchase order of 10,000 units , worth over $121.53K on May 13, 2022.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Burt Adelman's' Mailing Address?

  • Mailing address is Dyax Corp. 55 Network Drive Burlington MA 01803 MA

What are Verve Therapeutics, Inc's Past Insider Trades?

Verve Therapeutics, Inc's most recent insider trade came on December 5, 2023 by Krishna Yeshwant who bought 1,800,000 units worth $18M . In the last 2 years, insiders at Verve Therapeutics, Inc have sold an estimated value of $48.82M and bought an estimated value of $86.49M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Andrew Bellinger, CSO & CMO,  Sekar Kathiresan, Chief Executive Officer,  and Fmr Llc .

Verve Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...